LADENBURG THALMANN FINANCIAL SERVICES INC. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$14,000
+250.0%
272
+294.2%
0.00%
Q3 2019$4,000
-20.0%
69
-61.7%
0.00%
Q1 2019$5,000
-44.4%
180
-29.4%
0.00%
Q4 2018$9,000
-59.1%
255
-50.7%
0.00%
Q3 2018$22,000
-56.0%
517
-48.3%
0.00%
Q2 2018$50,0000.0%1,0000.0%0.00%
Q1 2018$50,000
-75.7%
1,000
-73.8%
0.00%
-100.0%
Q4 2017$206,000
-42.6%
3,819
-38.3%
0.00%
-50.0%
Q3 2017$359,000
+508.5%
6,194
+415.7%
0.00%
+300.0%
Q2 2017$59,000
+11.3%
1,201
-1.2%
0.00%0.0%
Q1 2017$53,000
-71.7%
1,215
-68.1%
0.00%
-66.7%
Q4 2016$187,000
+183.3%
3,812
+176.2%
0.00%
+200.0%
Q3 2016$66,000
-77.5%
1,380
-74.7%
0.00%
-80.0%
Q2 2016$293,000
+22.1%
5,456
+1.5%
0.01%
+25.0%
Q1 2016$240,000
+548.6%
5,376
+462.3%
0.00%
+300.0%
Q4 2015$37,000
+32.1%
956
+12.5%
0.00%0.0%
Q3 2015$28,0000.0%8500.0%0.00%0.0%
Q2 2015$28,000
-15.2%
850
+6.2%
0.00%0.0%
Q1 2015$33,000
+3.1%
8000.0%0.00%0.0%
Q4 2014$32,000
-79.2%
800
-81.0%
0.00%
-75.0%
Q3 2014$154,000
-42.8%
4,200
-27.6%
0.00%
-42.9%
Q2 2014$269,000
+13.0%
5,8000.0%0.01%0.0%
Q1 2014$238,000
+7.7%
5,8000.0%0.01%0.0%
Q4 2013$221,000
+1127.8%
5,800
+673.3%
0.01%
+600.0%
Q3 2013$18,0007500.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders